Booster Shots

Oddities, musings and some news from the world of health.

| Main |

FDA posts list of drugs that may be unsafe

1:54 PM, September 5, 2008

Drugs1 Score one for the consumer. The U.S. Food and Drug Administration today published its first list of drugs that are on the market and being used by consumers but are under review for potential safety issues.

The list, which will be updated quarterly, was part of the FDA Amendments Act, signed into law one year ago. The law requires that the FDA inform the public each quarter of new safety information or potential signals of serious risk based on the agency's review of adverse event reports.

The FDA explains the list: "The appearance of a drug on this list does not mean that FDA has concluded that the drug has the listed risk, or that FDA has identified a causal relationship between the drug and the listed risk. It is on the list only because FDA has identified a potential safety issue."

Dr. Janet Woodcock, direct of the FDA's Center for Drug Evaluation and Research added:

"My message to patients is this: Don't stop taking your medicine. If your doctor has prescribed a drug that appears on this list, you should continue taking it unless your doctor advises you differently."

The list contains 20 drugs along with the potential safety issue of each drug. Today's report includes the antidepressant Cymbalta and links to urinary retention; the multiple sclerosis drug Tysabri and reports of melanoma skin cancer, and the drug Revlimid for multiple myeloma that is linked to a life-threatening skin condition called Stevens Johnson Syndrome.

The list comes in response to complaints by the public and physicians that they aren't being told soon enough of potential safety problems reported to the FDA. Sometimes pre-marketing clinical trials do not produce evidence of a safety problem and it is only when the drug is in wide use that a problem emerges. The list will not be a comprehensive summary of all the drugs the FDA may be working on. Each new quarterly report will contain new listings; the lists will not be cumulative. You can read about the program at the FDA's website and see the current list of potentially unsafe drugs.

-- Shari Roan

Photo credit: Nati Harnik / AP

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c630a53ef00e554e60fb98833

Listed below are links to weblogs that referenceFDA posts list of drugs that may be unsafe:

Comments

Doesn't surprise me at all. Watch out for side effects and mention all side effects to your doctor.

How coincidental that last night I finished one of the most pertinent and enraging books I have read in many a long time: Melody Petersen's "Our Daily Meds". If you want to be disgusted and horrified about big pharma and their hand maidens, those 95%of the countries physicians that are in bed with them, read this book and you will never ever believe a medicine commercial again. And be thankful for that.

This FDA effort is a good thing. It creates a bit more transparency and provides a glimpse into undesirable drug effects, and issues that manufacturers can address.
Austin
http://drughealth.blogspot.com/
http://drughealth.mofuse.mobi/

Post a comment
If you are under 13 years of age you may read this message board, but you may not participate.
Here are the full legal terms you agree to by using this comment form.

Comments are moderated, and will not appear until they've been approved.

If you have a TypeKey or TypePad account, please Sign In





ADVERTISEMENT


Our Bloggers
Tami Dennis, who takes the word "skeptic" to previously uncharted territory, is the Times' Health and Science editor. She's adamant that pitches promoting awareness days, weeks or months are, by their nature, non-stories. And, because she's an adult, she refuses to use words like "veggies," "tummy" and "yummy."
Rosie Mestel, deputy Health and Science editor, studied genetics before abandoning flies, fungi and DNA for health/medical writing. Her hero is the biologist Ernst Haeckel, whose jellyfish paintings inspired snazzy chandeliers. Her favorite toast-spread is Marmite, a British delicacy made of yeast extract. Her least-favorite word is "millenniums."
Melissa Healy is a staff writer for the Health section reporting from Washington D.C. Healy's a veteran of The Times' National staff, having covered the Pentagon, Congress, poverty and social welfare, the environment, and the White House before shifting to Health in 2003. She writes frequently about mental health and human behavior, about federal health policy, prescription medication and ethics in medicine. More wonk than wellness freak, Healy chooses to believe in the health benefits of coffee and wine, and considers water a better work-out medium than beverage.
Karen Kaplan covers genetics, stem cells and cloning. She and colleague Thomas H. Maugh II comprise about 25% of the unofficial MIT-Alumni-in-Journalism Club, and she is proud to have taken more math (5) than English (0) courses in college. Her contributions to Booster Shots will, she hopes, appear more frequently than postings to her mommy blog.
Thomas H. Maugh II has been a science and medical writer at the Times for 23 years. Before that, he was on the staff of the journal Science for 13 years. He has bachelor's degrees in English and chemistry from MIT and a doctorate in chemistry from UC Santa Barbara.
After a brief stint as a sports writer, Shari Roan turned to health journalism and has covered the topic for The Times for 18 years. She is the author of three books and the mother of two daughters, both teenagers who refer to her as a "health freak." She likes to jog, watch baseball and is very happy that dark chocolate contains some health benefit.
Jeannine Stein writes about fitness, sports medicine and obesity for the Health section. She’s a gym rat from way back and never met an elliptical trainer she didn’t like. Well, maybe one or two. She tempers exercise with a steady diet of reality television because she believes it’s all about balance.